Showing results (611-620 of 648) with videos related to

Sort By:
Pageof 65
Scientific Reports|October 2, 2019
Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasionLaura M Prolo, Amy Li, Scott F Owen, et al.
Scientific Reports|July 12, 2020
PPARβ/δ-dependent MSC metabolism determines their immunoregulatory propertiesR A Contreras-Lopez, R Elizondo-Vega, M J Torres, et al.
Thrombosis and Haemostasis|March 7, 2014
From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysmR Martinez-Pinna, J S Lindholt, J Madrigal-Matute, et al.
Breast Cancer : Basic and Clinical Research|February 27, 2016
Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer PatientsAna de la Torre, Kirenia Pérez, Aliz M Vega, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2014
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancersUlrik N Lassen, Didier Meulendijks, Lilian L Siu, et al.
The Science of the Total Environment|March 18, 2019
Unusual winter Saharan dust intrusions at Northwest Spain: Air quality, radiative and health impactsF Oduber, A I Calvo, C Blanco-Alegre, et al.
Journal of Clinical Pharmacology|May 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspectiveThorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspectiveThorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Pageof 65